Stelara (Ustekinumab) is indicated for the treatment of adult patients with moderately to severely active Crohn's disease who have: • failed or were intolerant to treatment with immunomodulators or corticosteroids, but never failed treatment with a tumor necrosis factor (TNF) blocker, or • failed or were intolerant to treatment with one or more TNF blockers.
Ustekinumab is used to treat psoriasis. This includes psoriatic arthritis when it affects the skin. It is indicated for the treatment of adult patients (18 years and older) with moderate to severe plaque psoriasis (Ps) who are candidates for phototherapy or systemic therapy, and adult patients with active psoriatic arthritis (PsA) alone or in combination with methotrexate. It was also approved to treat Crohn's disease in September 2016.
For procurement cost of Stelara (Ustekinumab) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 / 9891296838 or Email Us to know more details about the medicine and its cost price in India.
Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA.
For Indian Patients Stelara (Ustekinumab) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India.
For overseas patient Stelara (Ustekinumab) brand in India can be also made available to overseas patients, doctors and hospitals. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.